2026-10-13T06:57:27Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33923277 2026-09-18T07:40:07Z category_37339 category_37354 category_37360 category_37366 portal_1012 item_type_3 month_year_09_2026

Supplementary Table S4 from A Phase II Study of Berzosertib in Combination with Carboplatin Compared with Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer Atish D. Choudhury (14939321) Caiwei Zhong (25070889) Wanling Xie (15062851) Bose S. Kochupurakkal (15062881) Peter I-Fan Wu (25070892) Irbaz Bin Riaz (25070895) Ruolin Liu (25070898) David D. Yang (18725256) Edmund Folefac (15062863) Daniel Lee (18099481) Mamta Parikh (15062872) David J. Einstein (14955423) Elizabeth R. Kessler (16157680) Tina Mayer (24412609) Rana R. McKay (15062884) Amanda Pace (25070901) Kent W. Mouw (15925720) Li Chen (18949726) Viktor A. Adalsteinsson (22053096) Eliezer M. Van Allen (15054227) Charles A. Kunos (25070904) Steven D. Gore (22549701) Biswajit Das (15035081) Alan D’Andrea (25070907) Mary-Ellen Taplin (17755430) Geoffrey I. Shapiro (14961801) Cancer Molecular and Cellular Biology Therapeutic Research and Development Clinical Research and Trials Clinical Trial Results Phase II clinical trials Dna Damage And Repair Prostate Cancer Small Molecule Agents DNA-reactive agents <p>Summary of blood- and tissue-based biomarkers</p> 2026-09-18T00:00:00Z Dataset Dataset 10.1158/2767-9764.33923277 https://figshare.com/articles/dataset/Supplementary_Table_S4_from_A_Phase_II_Study_of_Berzosertib_in_Combination_with_Carboplatin_Compared_with_Docetaxel_with_Carboplatin_in_Metastatic_Castration-Resistant_Prostate_Cancer/33923277 CC BY